Operation Warp Speed: The Untold Story of the COVID-19 Vaccine

October 18, 2023

(Vanity Fair) – On a chilly day in mid-April 2020, Moncef Slaoui, the retired head of the vaccine department at the pharmaceutical giant GlaxoSmithKline, was sitting by his unopened pool in Gladwyne, Pennsylvania, when his phone rang. The hopeful hint of spring in the air belied the dark desperation that suffused the world as the COVID-19 pandemic raged and the world’s wealthiest country struggled to figure out a way forward.

The caller was Jim Greenwood, a former Republican congressman from Pennsylvania who, since 2005, had served as the CEO of the trade association BIO, short for the Biotechnology Innovation Organization. Greenwood was reaching out after getting a call from Secretary of Health and Human Services Alex Azar. He had an urgent question for Slaoui: “Do you think that if you had unlimited resources, money, and people that we could have a vaccine against COVID-19 widely available by the end of the year?” (Read More)